Methodology to account for uncertainties and tradeoffs in pharmaceutical environmental hazard assessment

Journal of Environmental Management

Volumn 98, Issue 1, 2012, Pages 183-190

  Coutu, Sylvain ^a   Rossi, Luca ^a   Barry, D A ^a   Chèvre, Nathalie ^b  

^a EPFL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Environmental hazard; Expert judgment; Micropollutants; Multi criteria analysis; Pharmaceuticals

Indexed keywords

ANTIBIOTICS; CHEMICAL HAZARDS; CHEMICAL PROPERTIES; ENVIRONMENTAL IMPACT; PROBABILITY DENSITY FUNCTION; UNCERTAINTY ANALYSIS;

ENVIRONMENTAL HAZARDS; EXPERT JUDGMENT; HAZARD ASSESSMENT; HAZARD RANKING; HUMAN HEALTH; MICROPOLLUTANTS; MULTICRITERIA ANALYSIS; PHARMACEUTICAL PRODUCTS; PHYSICOCHEMICAL PROPERTY; UNCERTAINTY;

RISK ASSESSMENT;

ERYTHROMYCIN; ETHINYLESTRADIOL; TESTOSTERONE;

ALCOHOL; ANTIBIOTICS; AQUATIC ORGANISM; CONCENTRATION (COMPOSITION); DRUG; ENVIRONMENTAL IMPACT; ENVIRONMENTAL PROTECTION; HAZARD ASSESSMENT; HEALTH RISK; HISTOGRAM; HORMONE; LITERATURE REVIEW; PHYSICOCHEMICAL PROPERTY; POLLUTANT; POLLUTION EFFECT; TRADE-OFF; UNCERTAINTY ANALYSIS;

AQUATIC SPECIES; ARTICLE; DENSITY FUNCTIONAL THEORY; ENVIRONMENTAL IMPACT ASSESSMENT; ENVIRONMENTAL PROTECTION; HAZARD ASSESSMENT; HAZARDOUS WASTE; HISTOGRAM; HUMAN IMPACT (ENVIRONMENT); PHARMACEUTICAL WASTE; PHYSICAL CHEMISTRY; PROBABILITY; PROCESS DESIGN; SWITZERLAND; WATER CONTAMINATION;

SWITZERLAND;

EUCLIDIA;

EID: 84856799576     PISSN: 03014797     EISSN: 10958630     Source Type: Journal    
DOI: 10.1016/j.jenvman.2012.01.001     Document Type: Article

References (44)

1. Alexander K.S., Moglia M., Miller C. Water needs assessment: learning to deal with scale, subjectivity and high stakes. Journal of Hydrology 2010, 388:251-257.
2. Aragonés-Beltrán P., Mendoza-Roca J., Bes-Piá A., García-Melón M., Parra-Ruiz E. Application of multicriteria decision analysis to jar-test results for chemicals selection in the physical-chemical treatment of textile wastewater. Journal of Hazardous Materials 2009, 164:288-295.
3. Besse J.P., Garric J. Human pharmaceuticals in surface waters: implementation of a prioritization methodology and application to the French situation. Toxicology Letters 2008, 176:104-123.
4. BIPM Evaluation of Measurement Data - Guide to the Expression of Uncertainty in Measurement 2008, JCGM, Site last accessed on September 2011. http://www.bipm.org/en/publications/guides/gum.html.
5. Bisceglia K., Roberts A. The utility of "back-of-the-envelope" approaches to prioritizing environmental occurrence and risk studies on human pharmaceuticals, SETAC 26th annual meeting in North America. Environmental Science in a Global Society 2005, Baltimore, MD.
6. Bolger F., Wright G. Assessing the quality of expert judgment: issues and analysis. Decision Support Systems 1994, 11:1-24.
7. Bound J.P., Voulvoulis N. Pharmaceuticals in the aquatic environment - a comparison of risk assessment strategies. Chemosphere 2004, 56:1143-1155.
8. Bowman A., Azzalani A. Applied Smoothing Techniques for Data Analysis 1997, Oxford University Press, New York.
9. Bruce G.M., Pleus R.C., Snyder S.A. Toxicological relevance of pharmaceuticals in drinking water. Environmental Science & Technology 2010, 44:5619-5626.
10. Camacho-Munõz D., Martín J., Santos J., Aparicio I., Alonso E. Occurrence, temporal evolution and risk assessment of pharmaceutically active compounds in Doñana Park (Spain). Journal of Hazardous Materials 2010, 183:602-608.
11. Carballa M., Omil F., Lema J.M. Calculation methods to perform mass balances of micropollutants in sewage treatment plants. Application to pharmaceuticals and personal care products (PPCPs). Environmental Science & Technology 2007, 41:884-890.
12. Carballa M., Omil F., Lema J.M. Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage. Chemosphere 2008, 72:1118-1123.
13. Carlsson C., Johansson A.K., Alvan G., Bergman K., Kühler T. Are pharmaceuticals potent environmental pollutants?: Part I: environmental risk assessments of selected active pharmaceutical ingredients. Science of the Total Environment 2006, 364:67-87.
14. Conley J.M., Symes S.J., Schorr M.S., Richards S.M. Spatial and temporal analysis of pharmaceutical concentrations in the upper Tennessee River basin. Chemosphere 2008, 73:1178-1187.
15. Cooper E.R., Siewicki T.C., Phillips K. Preliminary risk assessment database and risk ranking of pharmaceuticals in the environment. Science of the Total Environment 2008, 398:26-33.
16. Cressie N. Statistics for Spatial Data 1991, John Wiley and Sons.
17. Cunningham V.L., Binks S.P., Olson M.J. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment. Regulatory Toxicology and Pharmacology 2009, 53:39-45.
18. Enick O.V., Moore M.M. Assessing the assessments: pharmaceuticals in the environment. Environmental Impact Assessment Review 2007, 27:707-729.
19. European Commission Technical Guidance Document in Support of Commissions Directive 93/67/EEC on Risk Assessment for New Notified Substances and Commissions Regulation (EC) 1996, Site last accessed on January 2011. http://ihcp.jrc.ec.europa.eu.
20. European Commission Regulation (EC) No 1907/2006 of the European Parliament and of the Council. Official Journal of the European Union 2006, Site last accessed on September 2011. http://eur-lex.europa.eu.
21. Howell W., Honey R. Expert evidence and how to be a good witness. Journal of Planning and Environment Law 2010, 10:1200-1216.
22. Jjemba P.K. Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. Ecotoxicology and Environmental Safety 2006, 63:113-130.
23. Jones O.A.H., Voulvoulis N., Lester J.N. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Research 2002, 36:5013-5022.
24. Kumar A., Xagoraraki I. Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: a proposed ranking system. Science of the Total Environment 2010, 408:5972-5989.
25. Pharmaceuticals in the Environment. Sources, Fate, Effects and Risks 2001, Springer, Heidelberg. K. Kummerer (Ed.).
26. Kummerer K., Velo G. Ecopharmacology: a new topic of importance in pharmacovigilance. Drug Safety 2006, 29:371-373.
27. Langford K.H., Thomas K.V. Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works. Environment International 2009, 35:766-770.
28. Lithner D., Larsson A., Dave Gõran Environmental and health hazard ranking and assessment of plastic polymers based on chemical composition. Science of the Total Environment 2011, 409:3309-3324.
29. Loffler D., Rombke J., Meller M., Ternes T.A. Environmental fate of pharmaceuticals in water/sediment systems. Environmental Science & Technology 2005, 39:5209-5218.
30. Logue J.M., McKone T.E., Sherman M.H., Singer B.C. Hazard assessment of chemical air contaminants measured in residences. Indoor Air 2011, 21:92-109.
31. Morse S., McNamara N., Acholo M., Okwoli B. Sustainability indicators: the problem of integration. Sustainable Development 2001, 9:1-15.
32. Newman A. Ranking pesticides by environmental impact. Environmental Science & Technology 1995, 29:324A-326A.
33. OFEV Rapport explicatif relatif à la Modification de l'ordonnance sur la protection des eaux (OE aux) 2009, Site last accessed on October 2011. http://www.news.admin.ch/NSBSubscriber/message/attachments/17613.pdf.
34. Perazzolo C., Morasch B., Kohn T., Magnet A., Thonney D., Chèvre N. Occurrence and fate of micropollutants in the Vidy Bay of Lake Geneva, Switzerland. Part I: priority list for environmental risk assessment of pharmaceuticals. Environmental Toxicology and Chemistry 2010, 29:1649-1657.
35. Rashid M.M., Hayes D.F. Needs-based sewerage prioritization: alternative to conventional cost-benefit analysis. Journal of Environmental Management 2011, 92:2427-2440.
36. Sanderson H., Johnson D.J., Reitsma T., Brain R.A., Wilson C.J., Solomon K.R. Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. Regulatory Toxicology and Pharmacology 2004, 39:158-183.
37. Santos J.L., Aparicio I., Callejón M., Alonso E. Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain). Journal of Hazardous Materials 2009, 164:1509-1516.
38. Sorvari J., Seppälä J. Adecision support tool to prioritize risk management options for contaminated sites. Science of the Total Environment 2010, 408:1786-1799.
39. Ternes T.A., Joss A. Human Pharmaceuticals, Hormones and Fragrances: The Challenge of Micropollutants in Urban Water Management 2006, IWA Publishing, London U.K.
40. Tosato M.L., Vigano L., Skagerberg B., Clementi S. Anew strategy for ranking chemical hazards. Framework and application. Environmental Science & Technology 1991, 25:695-702.
41. Valcárcel Y., González Alonso S., Rodríguez-Gil J., Gil A., Catalá M. Detection of pharmaceutically active compounds in the rivers and tap water of the Madrid Region (Spain) and potential ecotoxicological risk. Chemosphere 2011, 84:1336-1348.
42. Walls L., Quigley J. Building prior distributions to support Bayesian reliability growth modelling using expert judgement. Reliability Engineering & System Safety 2001, 74:117-128.
43. Webb S., Ternes T., Gibert M., Olejniczak K. Indirect human exposure to pharmaceuticals via drinking water. Toxicology Letters 2003, 142:157-167.
44. WHO Guideline for Drinking Water Quality. Recommendations 2008, vol. 1. World Health Organization, Geneva.